Stay updated on AT1001 Long-term Safety Study in Fabry Disease Clinical Trial
Sign up to get notified when there's something new on the AT1001 Long-term Safety Study in Fabry Disease Clinical Trial page.

Latest updates to the AT1001 Long-term Safety Study in Fabry Disease Clinical Trial page
- Check4 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA 403 Forbidden error is now displayed on the study record page, making the detailed study content inaccessible. This change blocks access to the study's information and reflects an access-restriction rather than new data updates.SummaryDifference17%

- Check46 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, signaling a minor maintenance update to the ClinicalTrials.gov entry. This update does not reflect changes in the study data.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page content has been replaced with a generic error page (500) and the detailed Migalastat Fabry disease study information has been removed.SummaryDifference16%

- Check81 days agoChange DetectedThe page's revision indicator was updated from v3.6.3 to v3.6.4, reflecting a minor update to the page's version metadata.SummaryDifference0.1%

- Check103 days agoChange DetectedThe page's revision label now reads v3.6.3, replacing the previous v3.6.2. This indicates a minor update to the page's release/version information.SummaryDifference0.1%

Stay in the know with updates to AT1001 Long-term Safety Study in Fabry Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AT1001 Long-term Safety Study in Fabry Disease Clinical Trial page.